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Abstract
Poorer performance on standard tests of pre-morbid cognitive function is related to an elevated risk of death from lower 
respiratory tract infections but the link with coronavirus (COVID-19) mortality is untested. Participants in UK Biobank, aged 
40 to 69 years at study induction (2006–10), were administered a reaction time test, an indicator of information processing 
speed, and also had their verbal-numeric reasoning assessed. Between April 1st and September 23rd 2020 there were 388 
registry-confirmed deaths (138 women) ascribed to COVID-19 in 494,932 individuals (269,602 women) with a reaction 
time test result, and 125 such deaths (38 women) in the subgroup of 180,198 people (97,794 women) with data on verbal-
numeric reasoning. In analyses adjusted for age, sex, and ethnicity, a one standard deviation slower reaction time was related 
to a higher rate of death from COVID-19 (hazard ratio; 95% confidence interval: 1.18; 1.09, 1.28), as was a one standard 
deviation disadvantage on the verbal-numeric reasoning test (1.32; 1.09, 1.59). While there was some attenuation in these 
relationships after adjustment for additional covariates which included socio-economic status and lifestyle factors, the two 
pre-pandemic indicators of cognitive function continued to be related to COVID-19 mortality.
Keywords COVID-19 · Cognitive function · Cohort
Introduction
Cognitive function—also referred to as mental ability or 
intelligence—refers to psychological functions that involve 
the storage, selection, manipulation, and organisation of 
information, and the planning of actions. Evidence from 
well-characterised cohort studies suggest that lower scores 
on standard tests of cognition are linked to elevated rates of 
premature mortality and cardiovascular disease [1]. Similar 
inverse relations have recently been reported for cognition 
and death from respiratory infection, comprising pneumonia 
and influenza [2]. Various explanations have been advanced, 
including the observation that people with higher cognitive 
ability are better equipped to obtain, process, and respond to 
disease prevention advice, as well as having healthier behav-
iours which include a lower prevalence of cigarette smoking 
[3], itself a risk factor for pneumonia [4].
These observations inevitably raise the possibility that 
individuals with lower mental ability may experience a 
higher burden of COVID-19. In a recent examination of 
primary care records, relative to an unaffected group, peo-
ple with intellectual disability experienced around ten times 
the risk of death ascribed to COVID-19 and five times the 
risk of hospitalisation, even after adjustment for age and 
other co-morbidities [5]. In a field-based cohort study of a 
non-disabled population, of a range of baseline psychoso-
cial factors, cognitive function was the most strongly predic-
tive of hospitalisation for COVID-19, whereby a doubling 
of disease risk was apparent in the lowest scoring group 
[6]. With the pandemic evolving since we published those 
analyses using UK Biobank [6], there is now a sufficiently 
high number of deaths in this study to examine if similar 
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results are apparent for pre-pandemic cognitive function and 
COVID-19 mortality—an association which, to the best of 
our knowledge, has yet to be tested.
Methods
Between 2006 and 2010, baseline data were collected in 
the UK Biobank, a prospective cohort study. Conducted 
across 22 research assessment centres, a total of 502,655 
individuals aged 40 to 69 years participated (response 5.5%) 
[7]. Ethical approvals were received from the North-West 
Multicentre Research Ethics Committee. Data are publicly 
available upon application (https:// www. ukbio bank. ac. uk/), 
and the present analyses of anonymised data did not require 
further ethical permissions.
Assessment of cognitive function
We use two tests of cognitive function as administered at 
baseline. Verbal and numeric (‘verbal-numeric’) reasoning 
was assessed using a computerized 13-item multiple-choice 
test with a two-minute time limit. The score derived was the 
number of correct answers. This test was introduced during 
the baseline assessment period; therefore, data are available 
for a subset of study members only (N = 180,914). Reac-
tion time, which captures speed of information processing, 
is a knowledge-reduced indicator of cognition. Measured in 
the present study using a computerized Go/No-Go “Snap”-
type game (N = 496,882), participants were presented with 
electronic images of two cards. If symbols on the cards 
were identical, participants were instructed to immediately 
push the button-box using their dominant hand. The first 
five pairs were used as a practice with the remaining seven 
pairs, containing four identical cards, forming the assess-
ment. Reaction time score was the mean time (milliseconds) 
taken to depress the button after each of these four matching 
pairs was presented. Reaction time correlates with cognitive 
tests that involve complex reasoning and knowledge such 
that people with higher cognitive ability tend to have faster 
reaction times [8].
Assessment of confounding factors
Covariates were also assessed at baseline. Socioeconomic 
status was quantified using self-reported educational 
qualifications (degree, other qualifications, no qualifica-
tions), occupational classification based on current job, 
and the Townsend index of neighbourhood deprivation 
(higher scores denote greater disadvantage). Ethnicity was 
categorised as White, Asian, Black, Chinese, Mixed, or 
‘other’ ethnic group. Vascular or heart problems, diabetes, 
chronic bronchitis or emphysema, and asthma, were based 
on self-report of a physician diagnosis. Hypertension was 
defined as systolic/diastolic blood pressure ≥ 140/90 mmHg 
and/or self-reported use of antihypertensive medication. 
Study members were also asked whether they had ever been 
under the care of a psychiatrist for any mental health prob-
lem. C-reactive protein, glycated haemoglobin, and high-
density lipoprotein cholesterol concentrations were based 
on assays of non-fasting venous blood. Height, weight–from 
which body mass index was computed–and forced expira-
tory volume in one second were measured using standard 
protocols. Cigarette smoking, physical activity, and alco-
hol consumption were assessed using standard enquiries. 
Study members were linked to national mortality records 
and death from COVID-19, our outcome of interest, was 
denoted by the emergency ICD-10 code U07.1 (COVID-19, 
virus identified).
Statistical analyses
To summarise the relation between cognition and mortal-
ity we used Cox regression to compute hazard ratios with 
accompanying 95% confidence intervals. In these analy-
ses we calculated effect estimates for tertiles of scores 
for both the test of verbal-numeric reasoning (< 4 [most 
disadvantaged], 5–6, ≥ 7) and reaction time (≤ 499 ms, 
500–581, ≥ 582 [most disadvantaged]). We also computed 
hazard ratios for a unit (standard deviation) disadvantage in 
score for verbal numeric reasoning (per 2.16 point decrease) 
and reaction time (per 118.2 ms increase). The most basic 
analyses were adjusted for known COVID-19 risk factors 
(age, sex, and ethnicity). Retaining these covariates, we then 
explored the impact of separately controlling for socioeco-
nomic circumstances, existing medical conditions, lifestyle 
factors, and biological indices.
Results
In 502,655 study members (273,472 women), 404 deaths 
(145 in women) were ascribed to COVID-19 between April 
1st and September 23rd 2020. In Table 1, in age-, sex- and 
ethnicity-adjusted analyses, we show, individually, the rela-
tion of the covariates and cognitive data with death from 
COVID-19. Twenty covariates were related to a higher risk 
of death from COVID-19 in these minimally-adjusted analy-
ses; only the point estimate for regular intake of alcohol 
and asthma did not achieve statistical significance at con-
ventional levels. Thus, there was a raised risk of COVID-
19 death in people who were older, male, of ethnic minor-
ity ancestry, and socioeconomically disadvantaged. Those 
study members who smoked, reported less physical activity, 
and had higher body mass index, those with extant illness 
at baseline, and those with unfavourable levels of known 
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cardiovascular disease biomarkers—lower lung function, 
higher systemic inflammation, lower high-density lipopro-
tein, and higher glycated haemoglobin—also experienced 
elevated rates of COVID-19 mortality.
In analyses adjusted for age, sex, and ethnicity, individu-
als with lower verbal-numeric reasoning scores had a higher 
risk of death ascribed to COVID-19 (hazard ratio per SD 
disadvantage; 95% confidence interval: 1.32; 1.09, 1.59) 
(Tables 1 and 2). Whereas adjusting for markers of socio-
economic position and biological factors had little impact 
on these effect estimates, adding co-morbidity to the mul-
tivariable model led to some attenuation (1.25; 1.04, 1.52). 
The greatest degree of attenuation, however, was evident 
after adjusting for lifestyle indices (1.16; 0.96, 1.41) which 
included smoking and body weight.
Associations with COVID-19 mortality are also shown by 
tertiles of the cognitive exposures in Table 2. In minimally-
adjusted analyses (age, sex, ethnicity), relative to the highest 
performing tertile of verbal-numeric reasoning, those peo-
ple in the lowest-scoring group experienced a doubling in 
the rate of death from COVID-19 (2.04; 1.30, 3.20). There 
was also evidence of a dose–response effect such that the 
intermediate cognition group (1.35; 0.86, 2.14) experienced 
an intermediate level of risk (P for trend: 0.002). Covari-
ate control had little impact on these results, the exception 
being lifestyle factors. In those analyses, although rates of 
COVID-19 mortality were still associated with around a 50% 
increase risk in the lowest cognition-scoring group (1.52; 
0.95, 2.43), statistical significance at conventional levels 
was lost.
Table 1  Cognitive function and covariates at baseline (2006–2010) according to death from COVID-19 (2020)
Hazard ratios are adjusted for age, sex, and ethnicity and expressed per category, or per SD increase for continuous variables (except for reason-
ing which is expressed per SD decrease [disadvantage]). The maximum analytical sample of 502,655 people was lower in selected analyses 
owing to missing data






Age, year, mean (SD) 62.7 (6.03) 56.5 (8.09)  < 0.0001 3.07 (2.67, 3.53)
Female, N (%) 145 (35.9) 273,327 (54.4)  < 0.0001 0.48 (0.38, 0.59)
Non-white ethnicity 37 (9.27) 26,997 (5.41) 0.001 3.75 (2.67, 5.27)
Comorbidities
Vascular or heart disease, N (%) 216 (54.3) 149,139 (29.8)  < 0.0001 1.79 (1.46, 2.19)
Hypertension, N (%) 313 (79.9) 282,324 (57.2)  < 0.0001 1.70 (1.32, 2.19)
Diabetes, N (%) 63 (15.8) 26,345 (5.27)  < 0.0001 2.31 (1.75, 3.06)
Chronic bronchitis or emphysema, N (%) 18 (4.46) 8,334 (1.66)  < 0.0001 2.37 (1.47, 3.80)
Asthma, N (%) 34 (8.42) 57,879 (11.5) 0.050 0.80 (0.56. 1.14)
Mental health—Psychiatric consultation, N (%) 56 (14.1) 57,625 (11.6) 0.117 1.42 (1.07, 1.88)
Lifestyle factors
Current smoker, N (%) 50 (12.6) 52,580 (10.5)  < 0.0001 1.88 (1.37, 2.59)
No physical activity, N (%) 55 (14.0) 32,804 (6.63)  < 0.0001 2.54 (1.90, 3.40)
Drinks alcohol daily/almost daily, N (%) 85 (21.3) 101,707 (20.3) 0.641 0.88 (0.69, 1.12)
Body mass index, kg/m2, mean (SD) 29.7 (5.83) 27.4 (4.80)  < 0.0001 1.51 (1.39, 1.65)
Biomarkers
Lung function, L, mean (SD) 2.53 (0.87) 2.81 (0.80)  < 0.0001 0.69 (0.60, 0.80)
C-reactive protein, mg/L, median (IQR) 1.72 (0.83, 3.51) 1.26 (0.63, 2.49) 0.0001 1.26 (1.12, 1.41)
High-density lipoprotein, mmol/L, median (IQR) 1.26 (1.09, 1.52) 1.40 (1.17, 1.67) 0.0001 0.79 (0.69, 0.90)
HbA1C, mmol/mol, median (IQR) 36.7 (33.8, 40.7) 35.2 (32.8, 37.9) 0.0001 1.25 (1.16, 1.35)
Socioeconomic factors
No university education, N (%) 310 (80.7) 330,988 (67.3)  < 0.0001 1.75 (1.35, 2.26)
Neighbourhood deprivation score, median (IQR) −0.887 (−3.04, −2.48) −2.14 (−3.64, 0.55) 0.0001 1.45 (1.33, 1.59)
Personal service, sales occupations etc., N (%) 54 (27.8) 66,160 (19.0) 0.002 1.57 (1.15, 2.16)
Cognitive factors
Verbal-numeric reasoning, mean (SD) 5.32 (2.20) 6.02 (2.16) 0.0002 1.32 (1.09, 1.59)
Reaction time, msec, mean (SD) 606.1 (136.4) 559.9 (118.2)  < 0.0001 1.18 (1.09, 1.28)
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Slower responders to the reaction time test had an ele-
vated risk of death from the disease (hazard ratio per SD 
disadvantage: 1.18; 1.09, 1.28) (Tables 1 and 2). In contrast 
to the analyses for verbal-numeric reasoning, there was less 
attenuation of estimates after controlling for the same covari-
ates (Table 2). Adjustment for lifestyle factors again resulted 
in the greatest attenuation of the cognition–mortality gradi-
ent but this was modest (1.15; 1.06, 1.25), and statistical 
significance at conventional levels was retained owing to 
the larger analytical sample in the reaction time analyses. 
Unlike the analyses of verbal-numeric reasoning, however, 
when the results were analysed by tertiles, there appeared to 
be a threshold effect in each model: only people in the slow-
est reaction time tertile had elevated risk; the hazard ratio in 
the intermediate group approximated 1. Collective control 
for all measured confounding factors did not impact further 
on the pattern of the relationship for death from COVID-19 
and our two indicators of cognitive function.
Lastly, given the known correlation for education and 
verbal-numeric reasoning (r = 0.40, p < 0.0001, N = 178,908 
in the present data), we conducted separate adjustment for 
education, one of three indicators of socioeconomic status 
used herein (Table 1a, appendix). Controlling for education 
had a marginal attenuating effect on the strength of the cog-
nition–COVID-19 death association, whereas the addition 
of the other socioeconomic factors of area deprivation and 
occupational classification led to positive confounding such 
that the magnitude of categorical effects increased some-
what. It is also the case, however, that, owing to some miss-
ing data for occupation, the apparent difference in strength 
of the association may at least partly reflect differences 
in sample size. With reaction time being a knowledge-
reduced measure of cognition, its relationship with educa-
tion (r = 0.15, p < 0.0001, N = 487,993) was weaker than for 
verbal-numeric reasoning.
Discussion
Our main finding was that, net of several covariates, poorer 
scores on two tests of cognition—verbal-numeric reasoning 
and reaction time—were associated with a higher risk of 
death from COVID-19. Patterns of attenuation were similar 
for both exposures such that the greater impact was apparent 
Table 2  Hazard ratios (95% confidence intervals) for the association of measures of baseline cognitive function (2006–2010) with death from 
COVID-19 (2020)
Comorbidities: diagnoses of vascular or heart disease, diabetes, chronic bronchitis or emphysema, asthma, hypertension, and mental illness
Socioeconomic status (SES): educational attainment, occupational classification, and area deprivation. Lifestyle factors: body mass index, smok-
ing status, alcohol intake, and physical activity. Biomarkers: Forced expiratory volume in the first second, and blood concentrations of C-reactive 
protein, glycated haemoglobin, and high-density lipoprotein
Adjusted for age, 
sex, and ethnicity
Adjusted for age, 
sex, ethnicity, and 
comorbidity
Adjusted for age, 
sex, ethnicity, and 
markers of socio-
economic status
Adjusted for age, 
sex, ethnicity, and 
lifestyle factors
Adjusted for age, 
sex, ethnicity, and 
biological factors





125/180,198 123/177,361 90/145,975 119/177,545 77/126,190 58/101,731
1 (most disadvan-
taged)
2.04 (1.30, 3.20) 1.86 (1.18, 2.93) 2.22 (1.26, 3.94) 1.52 (0.95, 2.43) 2.32 (1.30, 4.14) 2.33 (1.16, 4.69)
2 1.35 (0.86, 2.14) 1.29 (0.81, 2.03) 1.34 (0.78, 231) 1.27 (0.80, 2.01) 1.62 (0.90, 1.89) 1.39 (0.73, 2.67)
3 1.0 (reference) 1.0 1.0 1.0 1.0 1.0
P for trend 0.002 0.007 0.006 0.082 0.004 0.019
Per SD disadvan-
tage




388/494,932 378/483,785 182/339,977 373/484,832 250/352,096 122/243,954
1 1.0 (reference) 1.0 1.0 1.0 1.0 1.0
2 0.97 (0.73, 1.30) 0.92 (0.69, 1.24) 1.01 (0.67, 1.54) 0.94 (0.70, 1.27) 0.90 (0.62, 1.30) 0.84 (0.50, 1.43)
3 (most disadvan-
taged)
1.50 (1.15, 1.95) 1.40 (1.07, 1.83) 1.66 (1.13, 2.44) 1.35 (1.03, 1.77) 1.50 (1.08, 2.09) 1.75 (1.10, 2.77)
P for trend 0.001 0.003 0.004 0.009 0.003 0.006
Per SD disadvan-
tage
1.18 (1.09, 1.28) 1.16 (1.07, 1.27) 1.21 (1.07, 1.37) 1.15 (1.06, 1.25) 1.19 (1.07, 1.31) 1.22 (1.04, 1.43)
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after control for lifestyle factors, whereas physiological indi-
ces had little if any attenuating effect. We also replicated 
known risk factors for death from COVID-19—being older, 
male, from an ethnic minority, socioeconomically disadvan-
taged, and having an extant somatic medical condition have 
been repeatedly linked with poor prognosis in COVID-19 
patients in China [9] and elsewhere. Similarly, both verbal-
numeric reasoning (hazard ratio per SD disadvantage; 95% 
confidence interval: 1.17; 1.14, 1.20) and reaction time 
(1.15; 1.14, 1.16) demonstrated the expected associations 
[1, 10] with all-cause mortality (31,187 deaths in the full 
cohort) (Table 1b, appendix). The raised risk of COVID-
19 mortality seen in people with the most disadvantaged 
scores for reaction time—as described, a knowledge-reduced 
measure of cognition—corroborates the results for verbal-
numeric reasoning which is more closely linked to educa-
tion. It is also the case that the magnitude of association for 
scores on both tests were little attenuated after taking into 
account educational attainment.
Plausible mechanisms
There has been a deluge of health advice in the current pan-
demic during an era when news outlets and social media 
platforms have never been more ubiquitous. Preventative 
information has ranged from the simple and practical to the 
complex, contradictory, false, and fraudulent. In order to 
diminish their risk of the infection, the population has to 
acquire, synthesise, and deploy this information but the abil-
ity to do so seems to vary by levels of health literacy [11] 
just as it may for its close correlate, cognitive function.
Potential implications
People with low cognition scores may be conceptualised as 
being a vulnerable group. As well as seemingly having an 
elevated risk of death from COVID-19 in the present study, 
evidence suggests that people with lower ability report being 
less likely to take up the offer of a vaccine [12]. Lower cog-
nitive function may therefore represent a dual burden, as is 
perhaps also the case for ethnic minority groups and socio-
economically disadvantaged communities [6]. Further, given 
the current overabundance of health opinion, governments 
and public health agencies have an increased responsibility 
to provide simple and practical advice. This has not always 
been so in the UK during the pandemic.
Lifestyle factors explained the greatest portion of the 
association between cognition and death due to COVID-
19. As discussed, there is good evidence that people with 
lower ability have less favourable health behaviours—they 
are more likely to smoke, be physically inactive, have a 
less prudent diet, and drink heavily [3, 13–15]. The skills 
captured by cognition tests, such as comprehension and 
reasoning, may be important in the successful management 
of health behaviours. Behavioural modification advice could 
therefore be recalibrated to make it more suitable for people 
with lower ability.
Study strengths and weaknesses
The strengths of our study include the well-characterised 
nature of the sample and the full coverage of the population 
for cause of death. Our study also has some weaknesses. 
With the present sample not being representative of the gen-
eral UK population, death rates from leading causes and the 
prevalence of reported risk factors are known to be under-
estimates of those apparent in less select groups [7]; the 
same is likely to be the case for COVID-19 deaths. This 
notwithstanding, there is evidence that, for major causes of 
death, risk factor associations are externally valid [7]. Sec-
ondly, levels of our baseline data—exposures and covari-
ates—will vary in the period between study induction in 
UK Biobank and the present pandemic. This is a perennial 
issue in cohort studies and one we were able to investigate 
using data from a resurveys that took place in a sub-sample 
4 to 8 years after baseline examination. Analyses revealed 
moderate and similar levels of stability for verbal-numeric 
reasoning (r = 0.63, p < 0.001, N = 9689) and reaction time 
(r = 0.49, p < 0.001, N = 28,810) relative to key covari-
ates such as such as cigarette smoking (0.60, p < 0.001, 
N = 31,037), blood pressure (0.65, p < 0.001, N = 19,772), 
and diabetes (r = 0.63, p < 0.001, N = 31,037). Most obser-
vational studies in the context of chronic disease epidemiol-
ogy use a single baseline measurement of the exposure and 
relate it to disease onset. In the few analyses incorporating a 
repeat measurement, risk factor–disease associations appear 
to be strengthened [16] and we would anticipate the same 
for cognition. Lastly, as is inevitable, unmeasured confound-
ing factors may offer additional explanatory power in this 
observational study.
In conclusion, in the present study, poorer performance 
on two pre-pandemic indicators of cognitive function, 
including reaction time, a knowledge-reduced measure, was 
related to death ascribed to COVID-19.
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